A detailed history of Macroview Investment Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Macroview Investment Management LLC holds 373 shares of QURE stock, worth $6,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373
Previous 373 -0.0%
Holding current value
$6,490
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$5.63 - $8.27 $5,894 - $8,658
-1,047 Reduced 73.73%
373 $2,000
Q3 2023

Oct 26, 2023

BUY
$6.71 - $11.83 $3,375 - $5,950
503 Added 54.85%
1,420 $9,000
Q2 2023

Jul 13, 2023

BUY
$11.12 - $22.2 $10,197 - $20,357
917 New
917 $10,000
Q3 2020

Oct 23, 2020

SELL
$35.98 - $47.66 $2,446 - $3,240
-68 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$45.06 - $67.74 $3,064 - $4,606
68 New
68 $3,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $813M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.